South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Neurocrine Biosciences Inc. (NASDAQ:NBIX), a biopharmaceutical company focused on developing treatments for neurological and endocrine-related diseases, has been navigating a complex landscape of ...

Walking is a complex act, but one to which we give little thought. Step after step, day after day, it’s a recurring act. Five to ten thousand steps are taken on an average day by most Americans. This ...

" "target="_blank">President Dina Boluarte on Tuesday stated that the magnetic resonance imaging (MRI) system that is being made available to patients at the <a href=" Institute of Child Health ...

MNDs are neurological disorders that destroy motor neurons, the cells that control skeletal muscle activity such as walking, breathing, speaking, and swallowing.

Maharashtra reported 140 cases of the Zika virus disease in 2024, its highest since 2021, said a situation report published ...

Insights, Trends, Opportunities, and Recent DevelopmentsNew York, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Market Overview The ...

Equities research analysts at Leerink Partnrs reduced their FY2024 earnings per share estimates for Neurocrine Biosciences in ...

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price target hoisted by equities researchers at UBS Group from $162.00 to $176.00 in a research note issued to investors on ...

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug ...

A US Centers for Disease Control and Prevention (CDC)-led study identifies three clusters of post-COVID multisystem ...